Riabni
NDC 55513-224 · Amgen, Inc
Generic namerituximab-arrx
Dosage formINJECTION, SOLUTION
RouteINTRAVENOUS
Active ingredient(s)RITUXIMAB
Strength100 mg/10mL
Pharmacologic classCD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]
Marketing categoryBLA
Packages
55513-224-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-224-01) / 10 mL in 1 VIAL, SINGLE-DOSE
55513-224-21 — 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-224-21) / 10 mL in 1 VIAL, SINGLE-DOSE
Billed under HCPCS
Q5123 — Injection, rituximab-arrx, biosimilar, (riabni), 10 mg Medicare Part B payment limit (ASP + 6%): $18.53
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0069-0238 — rituximab-pvvr, 0069-0249 — rituximab-pvvr, 50242-051 — rituximab, 50242-053 — rituximab, 50242-108 — rituximab and hyaluronidase, 50242-109 — rituximab and hyaluronidase, 55513-326 — rituximab-arrx, 63459-103 — rituximab-abbs, 63459-104 — rituximab-abbs